| (84) |
Etats contractants désignés: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Etats d'extension désignés: |
|
AL LT LV MK RO SI |
| (30) |
Priorité: |
22.10.1999 FR 9913206
28.06.2000 FR 0008328
|
| (43) |
Date de publication de la demande: |
|
31.07.2002 Bulletin 2002/31 |
| (73) |
Titulaire: Sanofi-Aventis |
|
75013 Paris (FR) |
|
| (72) |
Inventeurs: |
|
- BARONI, Marco
I-20010 Vanzago (IT)
- BOURRIE, Bernard
F-34980 Saint Gély du Fesc (FR)
- CARDAMONE, Rosanna
I-22100 Como (IT)
- CASELLAS, Pierre
F-34090 Montpellier (FR)
- GUZZI, Umberto
I-20148 Milano (IT)
|
| (74) |
Mandataire: Varady, Peter et al |
|
Sanofi-Aventis
174 avenue de France
75013 Paris
75013 Paris (FR) |
| (56) |
Documents cités: :
US-A- 3 991 061
US-A- 5 776 939
|
US-A- 5 118 691
|
|
| |
|
|
- DATABASE CHEMABS [en ligne] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BOURRIE,
BERNARD ET AL: "The neuroprotective agent SR 57746A abrogates experimental autoimmune
encephalomyelitis and impairs associated blood-brain barrier disruption: implications
for multiple sclerosis treatment" retrieved from STN Database accession no. 132:30802
XP002142809 & PROC. NATL. ACAD. SCI. U. S. A. (1999), 96(22), 12855-12859,
- LOMBAERT S D ET AL: "Potent non-peptidic dual inhibitors of endothelin-converting
enzyme and neutral endopeptidase 24.11" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD,
vol. 7, no. 8, 22 avril 1997 (1997-04-22), pages 1059-1064, XP004136185 ISSN: 0960-894X
|
|
